A detailed history of Argyle Capital Management Inc. transactions in Viatris Inc stock. As of the latest transaction made, Argyle Capital Management Inc. holds 10,217 shares of VTRS stock, worth $136,499. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,217
Previous 10,655 4.11%
Holding current value
$136,499
Previous $113,000 4.42%
% of portfolio
0.05%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$10.32 - $12.13 $4,520 - $5,312
-438 Reduced 4.11%
10,217 $118,000
Q2 2024

Jul 29, 2024

BUY
$10.05 - $12.02 $5,989 - $7,163
596 Added 5.93%
10,655 $113,000
Q1 2024

Apr 29, 2024

SELL
$11.27 - $13.53 $3,989 - $4,789
-354 Reduced 3.4%
10,059 $120,000
Q4 2023

Feb 05, 2024

SELL
$8.77 - $10.85 $19,837 - $24,542
-2,262 Reduced 17.85%
10,413 $112,000
Q3 2023

Oct 26, 2023

SELL
$9.59 - $11.35 $949 - $1,123
-99 Reduced 0.78%
12,675 $124,000
Q2 2023

Jul 27, 2023

SELL
$9.02 - $10.29 $18,346 - $20,929
-2,034 Reduced 13.74%
12,774 $127,000
Q1 2023

Apr 27, 2023

SELL
$9.2 - $12.26 $1,821 - $2,427
-198 Reduced 1.32%
14,808 $142,000
Q3 2022

Oct 21, 2022

SELL
$8.48 - $11.13 $737 - $968
-87 Reduced 0.58%
15,006 $128,000
Q2 2022

Jul 20, 2022

SELL
$9.95 - $12.27 $10,238 - $12,625
-1,029 Reduced 6.38%
15,093 $158,000
Q1 2022

Apr 27, 2022

SELL
$9.81 - $15.4 $5,218 - $8,192
-532 Reduced 3.19%
16,122 $175,000
Q4 2021

Jan 25, 2022

SELL
$12.09 - $14.68 $5,984 - $7,266
-495 Reduced 2.89%
16,654 $225,000
Q3 2021

Oct 25, 2021

SELL
$13.25 - $15.13 $4,902 - $5,598
-370 Reduced 2.11%
17,149 $232,000
Q2 2021

Jul 27, 2021

SELL
$12.97 - $16.15 $3,929 - $4,893
-303 Reduced 1.7%
17,519 $250,000
Q1 2021

Apr 27, 2021

SELL
$13.59 - $18.54 $3,016 - $4,115
-222 Reduced 1.23%
17,822 $249,000
Q4 2020

Jan 28, 2021

BUY
$14.3 - $18.74 $258,029 - $338,144
18,044 New
18,044 $338,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Argyle Capital Management Inc. Portfolio

Follow Argyle Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Management Inc. with notifications on news.